.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Citi
Moodys
Daiichi Sankyo
McKinsey
Queensland Health
Dow
Boehringer Ingelheim
Novartis

Generated: December 12, 2017

DrugPatentWatch Database Preview

GANCICLOVIR Drug Profile

« Back to Dashboard

Which patents cover Ganciclovir, and what generic alternatives are available?

Ganciclovir is a drug marketed by Ranbaxy Labs Ltd, Fresenius Kabi Usa, Luitpold Pharms Inc, Par Sterile Products, Exela Pharma Scs Llc, and West-ward Pharms Int. and is included in six NDAs. There is one patent protecting this drug.

The generic ingredient in GANCICLOVIR is ganciclovir sodium. There are twenty-five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ganciclovir sodium profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs LtdGANCICLOVIRganciclovirCAPSULE;ORAL076457-001Jun 27, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntGANCICLOVIR SODIUMganciclovir sodiumINJECTABLE;INJECTION076222-001Jul 16, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Luitpold Pharms IncGANCICLOVIRganciclovir sodiumINJECTABLE;INJECTION202624-001Sep 18, 2013APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ranbaxy Labs LtdGANCICLOVIRganciclovirCAPSULE;ORAL076457-002Jun 27, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaGANCICLOVIRganciclovir sodiumINJECTABLE;INJECTION090658-001Jun 21, 2010APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Exela Pharma Scs LlcGANCICLOVIRganciclovir SOLUTION;IV (INFUSION)209347-001Feb 17, 2017RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Par Sterile ProductsGANCICLOVIRganciclovir sodiumINJECTABLE;INJECTION204950-001Dec 6, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Deloitte
Accenture
Johnson and Johnson
Harvard Business School
McKinsey
Fuji
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot